Dapagliflozin metformin XR
Showing 1 - 25 of 2,937
Healthy Volunteer Trial in Suzhou (Dapagliflozin/metformin XR FDC 5/500 mg, Dapagliflozin/metformin XR FDC 10/1000 mg,
Completed
- Healthy Volunteer
- Dapagliflozin/metformin XR FDC 5/500 mg
- +3 more
-
Suzhou, ChinaResearch Site
Apr 25, 2022
Compensated Cirrhosis, Decompensated Cirrhosis Trial in New Delhi (Metformin, Sitagliptin, Dapagliflozin)
Not yet recruiting
- Compensated Cirrhosis
- Decompensated Cirrhosis
- Metformin
- +2 more
-
New Delhi, Delhi, IndiaDr Rakesh Kumar Jagdish
Nov 23, 2023
Type2diabetes, Insulin Resistance Trial (Metformin, Dapagliflozin, Fixed-dose combination of metformin and pioglitazone (500mg
Not yet recruiting
- Type2diabetes
- Insulin Resistance
- Metformin
- +2 more
- (no location specified)
Oct 20, 2022
XIGDUO Extended Release (XR) Post Marketing Surveillance
Completed
- Adult Patients With Type 2 Diabetes Mellitus
-
Busan, Korea, Republic of
- +7 more
Jul 10, 2020
Obesity, Dapagliflozin Adverse Reaction, Weight Loss Trial (Dapagliflozin 10mg Tab)
Not yet recruiting
- Obesity
- +3 more
- Dapagliflozin 10mg Tab
- (no location specified)
Aug 14, 2023
PCO Trial in Bani Suwayf (Dapagliflozin 5 MG, Metformin Hydrochloride 1000 MG, Dapagliflozin/Metformin)
Recruiting
- PCO
- Dapagliflozin 5 MG
- +2 more
-
Banī Suwayf, Beni Suef, EgyptBeni-suef university
Oct 26, 2022
Type 2 Diabetes Trial in Bangkok, Ho Chi Minh (Dapagliflozin 10 mg, Dapagliflozin 5 mg, Dapagliflozin 10 mg to match)
Terminated
- Type 2 Diabetes Mellitus
- Dapagliflozin 10 mg
- +5 more
-
Bangkok, Thailand
- +3 more
May 25, 2022
Tendinopathy, Chronic Pain, Achilles Tendinopathy Trial in Pittsburgh (Metformin, Placebo)
Not yet recruiting
- Tendinopathy
- +2 more
- Metformin
- Placebo
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Oct 19, 2023
Type 2 Diabetes Trial in Sydney, Melbourne (Dapagliflozin, Metformin)
Not yet recruiting
- Type 2 Diabetes
-
Sydney, New South Wales, Australia
- +1 more
Apr 19, 2022
Type 2 Diabetes Trial in Bucheon (Dapagliflozin 10mg, Placebo, Evogliptin 5mg)
Completed
- Type 2 Diabetes
- Dapagliflozin 10mg
- +3 more
-
Bucheon, Korea, Republic ofThe Catholic University of Korea Bucheon St. Mary's Hospital
Mar 20, 2022
Fibromyalgia Syndrome Trial in Salt Lake City (Metformin, Placebo)
Active, not recruiting
- Fibromyalgia Syndrome
- Metformin
- Placebo
-
Salt Lake City, UtahUniversity of Utah
Jun 12, 2023
Type 2 Diabetes Trial (GMRx4 polypill - sitagliptin, dapagliflozin, metformin, Metformin)
Not yet recruiting
- Type 2 Diabetes
- GMRx4 polypill - sitagliptin, dapagliflozin, metformin
- Metformin
- (no location specified)
Apr 27, 2023
Healthy Trial in Darmstadt (Test Glucophage® XR, Reference Glucophage® XR)
Recruiting
- Healthy
- Test Glucophage® XR
- Reference Glucophage® XR
-
Darmstadt, GermanyResearch Site
Aug 10, 2022
Healthy Trial in Daejeon (Glucophage® XR Test, Glucophage® XR Reference)
Completed
- Healthy
- Glucophage® XR Test
- Glucophage® XR Reference
-
Daejeon, Korea, Republic ofClinical Trials Center, Chungnam National University Hospital
Mar 30, 2022
Type 2 Diabetes Trial in Seoul (JT-003, JT-003 Placebo)
Recruiting
- Type 2 Diabetes Mellitus
- JT-003
- JT-003 Placebo
-
Seoul, Korea, Republic ofSeoul National University Hospital
Mar 16, 2022
Type2 Diabetes Trial in Seoul (Metformin=1000mg, Pioglitazone 15mg, Pioglitazone 30 mg)
Active, not recruiting
- Type2 Diabetes
- Metformin≥1000mg
- +5 more
-
Seoul, Korea, Republic ofAsan Medical Center
Apr 12, 2022
Diabetes, Diabetes, Type 2, Glucose Metabolism Disorders Trial (DWP16001, Dapagliflozin Tablet)
Not yet recruiting
- Diabetes Mellitus
- +4 more
- DWP16001
- Dapagliflozin Tablet
- (no location specified)
Aug 16, 2022
Autosomal Dominant Polycystic Kidney Disease Trial in Australia (Metformin XR, Control)
Not yet recruiting
- Autosomal Dominant Polycystic Kidney Disease
- Metformin XR
- Control
-
Sydney, New South Wales, Australia
- +3 more
Nov 9, 2022
Type 2 Diabetes Trial in Seoul (JT-001, JT-001 Placebo)
Recruiting
- Type 2 Diabetes Mellitus
- JT-001
- JT-001 Placebo
-
Seoul, Korea, Republic ofSeverance Hospital
Mar 3, 2022
Low Back Pain Trial in Pittsburgh, Wexford (Metformin, Placebo)
Active, not recruiting
- Low Back Pain
- Metformin
- Placebo
-
Pittsburgh, Pennsylvania
- +1 more
Oct 28, 2022
Type 2 Diabetes Trial in Daejeon (CT-L01, Alogliptin Benzoate 25 mg, Metformin HCl XR 1,000 mg)
Completed
- Healthy
- CT-L01
- +2 more
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Jan 10, 2023
Type 2 Diabetes Trial in Daejeon (CT-L01 12.5/500 mg, Alogliptin Benzoate 12.5 mg, Metformin HCl XR 500 mg)
Completed
- Healthy
- CT-L01 12.5/500 mg
- +2 more
-
Daejeon, Korea, Republic ofChungnam National University Hospital
Jan 10, 2023
Lung Carcinoma Trial in Aurora, Buffalo, Vancouver (Extended Release Metformin Hydrochloride)
Recruiting
- Lung Carcinoma
- Biopsy
- +4 more
-
Aurora, Colorado
- +2 more
Jan 28, 2023
Pharmacokinetics Trial in Prague (Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine), Glucophage® XR 1000 mg
Completed
- Pharmacokinetics
- Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)
- Glucophage® XR 1000 mg Prolonged Release Tablets (Merck Serono Ltd, UK)
-
Prague, CzechiaQUINTA-ANALYTICA s.r.o.
Nov 9, 2021